Canagliflozin With Gemcitabine in Pancreatic Carcinoma

Clinical trial NCT05903703 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05903703
Sponsor: Zhang Xiaofeng,MD
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2023-10-01
Primary completion: 2026-09-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.